ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00098423
Brief Title: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

First Submitted : December 7, 2004
First Submitted that Met QC Criteria : December 7, 2004
First Posted : December 8, 2004 (Estimate)

Last Update Submitted that Met QC Criteria : September 27, 2013
Last Update Posted : September 30, 2013 (Estimate)